At last, we established a nomogram combining RPLP2 expression and some critical clinical features which exhibited significantly high value in predicting the 1-, 3-, and 5-year survival probability of the HCC patients (Fig. 7J, Additional file 1: Fig. S5A–C). Here, RPLP2 is linked to hepatocellular carcinoma.